Biotech - International Biopharmaceutical Industry

Volume 4 Issue 4

CGT CDMO Partnering: More than just Manufacturing

The biotech footprint has been exponentially expanding around the globe and no division has increased more feverishly in recent years than the Cell and Gene Therapy (...

9 December 2021 Volume 4 Issue 4 Biotech | CDMO

Continue Reading →

news

Blueprint, taking aim at larger drugmakers, becomes a biotech buyer

Lengo's drug targets a mutation in the gene that drives production of a protein called EGFR, which, in turn, can help spur tumor growth. The mutation, found in the ex...

3 December 2021 news Biotech | Blueprint

Continue Reading →

news

Moderna, teaming with a startup, wades further into gene editing

Before it rose to prominence as a vaccine maker, Moderna's original ambitions were to use its messenger RNA technology — a way to prompt the body's cells to produce h...

8 November 2021 news Biotech | gene-editing

Continue Reading →

news

Atea, Roche change plans for oral COVID-19 drug after trial setback

Atea's fast ascent last year was due to its plan to use a pill originally developed for hepatitis C infections as a treatment for COVID-19. The strategy resonated wit...

22 October 2021 news Atea | Biotech

Continue Reading →

news

CureVac scraps its first COVID-19 vaccine and pivots to a second

After months sticking with its coronavirus vaccine, CureVac has finally given up. CureVac executives had long argued the shot could still play a role in fighting COV...

15 October 2021 news aged 18-60 | Biotech

Continue Reading →

news

How a busy year for biotech IPOs measures up at the three-quarter mark

Two records set one year ago could fall, as the number of biotech companies going public and the total amount they've raised are each on pace to eclipse 2020's totals...

8 October 2021 news Biotech | IPOs

Continue Reading →

news

Sarepta embarks on late-stage clinical trial of Duchenne gene therapy

Although Pfizer beat Sarepta to start a Phase 3 trial of its gene therapy, the smaller biotech is claiming a milestone in initiating the study in the U.S. as well as ...

8 October 2021 news Biotech | Duchenne

Continue Reading →

news

Biotech funder Lightstone raises another $375M for life sciences investing

For the past few years, and especially since the coronavirus pandemic put healthcare in the spotlight, investors have flocked to young biotech companies. Their inter...

17 September 2021 news Biotech | coronavirus pandemic

Continue Reading →

news

Moderna founder’s next big play in RNA raises $440M

In about a year's time, Moderna went from an ambitious company with unproven technology to one of the world's most highly valued drug developers. Now, Flagship Pionee...

3 September 2021 news Biotech | Laronde

Continue Reading →

news

Hint of benefit in Alzheimer’s drug study fuel stock surge for Swiss biotech

A small clinical trial of a once-failed Alzheimer's drug offered tantalizing but inconclusive hints of benefit, propelling shares in its biotech maker higher by more ...

3 September 2021 news Alzheimer | Biogen

Continue Reading →